LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 8, 2025 / Renovaro Inc. (NASDAQ:RENB) was referenced in a recent RealClearDefense article titled "AI Can Be Used to Develop Biological and Chemical ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
We recently published a list of 11 AI News and Ratings You Probably Missed. In this article, we are going to take a look at where Renovaro Inc. (NASDAQ:RENB) stands against other AI news and ratings ...
Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, has ...
Short interest in Renovaro Inc (NASDAQ:RENB) increased during the last reporting period, rising from 4.69M to 5.00M. This put 4.04% of the company's publicly available shares short. Short interest in ...
We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take a look at where Renovaro Inc. (NASDAQ:RENB) stands against the other AI ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
LOS ANGELES, CALIFORNIA, UNITED STATES, April 30, 2024 /EINPresswire.com/ -- Launch of Groundbreaking Cancer Detection Platform Flamingo with Nvidia AI Computing ...
Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical Markets LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results